Results 101 to 110 of about 65,470 (161)
Identification of cellular factors associated with inflammation and neurodegeneration in multiple sclerosis
Frontiers in ImmunologyBackgroundSerum biomarkers as neurofilament light chain (sNfL) and glial fibrillary acidic protein (sGFAP) enabled early identification of multiple sclerosis (MS) patients at risk of relapse-associated worsening (RAW) or progression independent of ...Alexander Rodero-Romero, José Ignacio Fernández-Velasco, Enric Monreal, Raquel Sainz-Amo, Roberto Álvarez-Lafuente, Manuel Comabella, Manuel Comabella, Lluís Ramió-Torrentà, Lluís Ramió-Torrentà, Lluís Ramió-Torrentà, José M. García-Domínguez, Noelia Villarrubia, Susana Sainz de la Maza, María Domínguez-Mozo, Ana Quiroga-Varela, Juan Luís Chico-García, Fernando Rodriguez-Jorge, José Luis Veiga-Gonzalez, Ernesto Roldán-Santiago, Mercedes Espiño, Eulalia Rodríguez-Martín, Gary Álvarez, Jaime Masjuan, Xavier Montalban, Xavier Montalban, Lucienne Costa-Frossard, Luisa María Villar +26 moredoaj +1 more sourcePrevalencia de Esclerosis Múltiple en Lima - Perú
, 2009 La Esclerosis Múltiple (EM) es la principal enfermedad desmielinizante a nivel mundial. La epidemiología señala una mayor prevalencia de esta entidad en áreas alejadas de la línea ecuatorial.Alan Juárez Belaúnde, Darwin Vizcarra Escobar, Ana Chereque Gutierrez, Martin Tipismana Barbarán, Antonio Bernabé Ortiz, Jorge Kawano Castillo, Carlos Castañeda Barba +6 morecore Do immunosuppressive treatments influence immune responses against adenovirus-based COVID-19 vaccines in patients with multiple sclerosis? An Argentine multicenter study
Frontiers in ImmunologyIntroductionThere are no reports in LATAM related to longitudinal humoral and cellular response to adenovirus based COVID-19 vaccines in people with Multiple Sclerosis (pwMS) under different disease modifying therapies (DMTs) and neutralization of the ...Berenice Anabel Silva, Berenice Anabel Silva, Berenice Anabel Silva, Esteban Miglietta, Juan Cruz Casabona, Shirley Wenker, María Bárbara Eizaguirre, Ricardo Alonso, Magdalena Casas, Luciana Grimanesa Lázaro, Federico Man, Gustavo Portuondo, Abril Lopez Bisso, Noelia Zavala, Federico Casales, Gastón Imhoff, Dra Judith Steinberg, Pablo Adrián López, Edgar Carnero Contentti, Norma Deri, Vladimiro Sinay, Javier Hryb, Edson Chiganer, Felisa Leguizamon, Verónica Tkachuk, Johana Bauer, Flavia Ferrandina, Susana Giachello, Paula Henestroza, Orlando Garcea, Carla Antonela Pascuale, Mauro Heitrich, Osvaldo L. Podhajcer, Sabrina Vinzón, Tomas D’Alotto-Moreno, Alejandro Benatar, Gabriel Adrián Rabinovich, Fernando J. Pitossi, Carina C. Ferrari +38 moredoaj +1 more source[Periodic plasmapheresis as maintenance treatment in relapsing-remitting multiple sclerosis, a new therapeutic line? A case report]. [PDF]
Rev Neurol, 2022 Lafuente-Gómez G, Anaya-Fernández Lomana F, Gómez-Roldós A, García-Domínguez JM, Lozano-Ros A, Cuello JP, Higueras-Hernández Y, Meldaña-Rivera A, Goicochea-Briceño H, Leal-Hidalgo R, De Miguel-Sánchez de Puerta CJ, Martínez-Ginés ML. +11 moreeuropepmc +1 more sourceErratum to ‘‘Pulse immunosuppressive therapy for multiple sclerosis during the SARS-CoV-2 lockdown de-escalation plan: Safety algorithm’’ [Neurologia. 2020;35(6):357–362]
Neurología (English Edition), 2020 G. Valero-López, E. Carreón-Guarnizo, R. Hernández-Clares, F. Iniesta-Martínez, J. Jiménez-Veiga, A. Moreno-Docon, M.A. Iborra-Bendicho, E. Aznar-Robles, M.F. Hellín-Gil, A. Morales-Ortiz, J.E. Meca-Lallana +10 moredoaj +1 more sourceControversies in neuroimmunology: Multiple sclerosis and other demyelinating disorders [PDF]
BiomedicaVillegas AC, Cuéllar-Giraldo D, Rojo-Bustamante E, Zafra-Sierra MP, Burbano L, Medina T, Serna-Corredor LA, Ramírez MC, Rodríguez DS, Urbano M, Duque A, Toro J, Reyes S. +12 moreeuropepmc +1 more source